IDEV

Pharma giant assumes ownership of medical stent-producer IDEV

Abbott Laboratories is set to acquire all of IDEV Technologies' outstanding equity shares for US $30 million.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics